Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation

BACKGROUND: Serial management of renal anemia using continuous erythropoietin receptor activator (CERA) throughout the peritoneal dialysis initiation period has rarely been reported. We investigated the efficacy and dosage of CERA treatment from pre- to post-peritoneal dialysis initiation for anemia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Exp Nephrol
Hlavní autoři: Fujimoto, Daisuke, Adachi, Masataka, Miyasato, Yoshikazu, Hata, Yusuke, Inoue, Hideki, Oda, Akira, Kakizoe, Yutaka, Nakagawa, Terumasa, Shimasaki, Akiko, Nakamura, Keishi, Nagayoshi, Yu, Mukoyama, Masashi
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Singapore 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880977/
https://ncbi.nlm.nih.gov/pubmed/33025233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-020-01973-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky